国际医药卫生导报
國際醫藥衛生導報
국제의약위생도보
INTERNATIONAL MEDICINE & HEALTH GUIDANCE NEWS
2013年
17期
2720-2722
,共3页
肝素%新生儿%弥漫性血管内凝血%静脉注射%微计量
肝素%新生兒%瀰漫性血管內凝血%靜脈註射%微計量
간소%신생인%미만성혈관내응혈%정맥주사%미계량
Heparin%Neonate%Disseminated intravascular coagulation%Intravenous injection%Micro-metering
目的 探讨肝素在治疗新生儿弥漫性血管内凝血(DIC)中的剂量、给药方法及时机.方法 选择2010年10月至2013年4月我院发生DIC的40例新生儿为研究对象.将其随机分为实验组和对照组,各20例.所有患儿均行综合治疗,实验组早期静脉注射微剂量肝素治疗,对照组静脉注射常规剂量肝素治疗.观察比较两组患儿住院天数、住院费用、治愈率、病死率及不良反应发生情况.结果 实验组住院天数、住院费用、治愈率、病死率与对照组比较,差异均具有统计学意义(P＜0.05).所有存活患儿均无出血倾向.结论 早期静脉注射小剂量肝素治疗各期新生儿DIC,安全有效,不良反应少,值得临床推广使用.
目的 探討肝素在治療新生兒瀰漫性血管內凝血(DIC)中的劑量、給藥方法及時機.方法 選擇2010年10月至2013年4月我院髮生DIC的40例新生兒為研究對象.將其隨機分為實驗組和對照組,各20例.所有患兒均行綜閤治療,實驗組早期靜脈註射微劑量肝素治療,對照組靜脈註射常規劑量肝素治療.觀察比較兩組患兒住院天數、住院費用、治愈率、病死率及不良反應髮生情況.結果 實驗組住院天數、住院費用、治愈率、病死率與對照組比較,差異均具有統計學意義(P＜0.05).所有存活患兒均無齣血傾嚮.結論 早期靜脈註射小劑量肝素治療各期新生兒DIC,安全有效,不良反應少,值得臨床推廣使用.
목적 탐토간소재치료신생인미만성혈관내응혈(DIC)중적제량、급약방법급시궤.방법 선택2010년10월지2013년4월아원발생DIC적40례신생인위연구대상.장기수궤분위실험조화대조조,각20례.소유환인균행종합치료,실험조조기정맥주사미제량간소치료,대조조정맥주사상규제량간소치료.관찰비교량조환인주원천수、주원비용、치유솔、병사솔급불량반응발생정황.결과 실험조주원천수、주원비용、치유솔、병사솔여대조조비교,차이균구유통계학의의(P＜0.05).소유존활환인균무출혈경향.결론 조기정맥주사소제량간소치료각기신생인DIC,안전유효,불량반응소,치득림상추엄사용.
Objective To explore the dosage and medication method and time of heparin for neonatal disseminated intravascular coagulation(DIC).Methods 40 newborns with DIC chosen from our hospital from October 2010 to April 2013 were randomly divided into an experimental group and a control group,20 for each group.All patients underwent comprehensive treatment.The experimental group were intravenously injected a micro-dose of heparin,while the control group intravenously took a conventional dose of heparin.The cure rates,mortalities,hospitalization cost,length of hospital stay,and adverse occurrences of both groups were observed.Results There were statistical differences in cure rate,mortality,length of hospital stay,hospitalization cost,and mortality between the experimental group and the control group(P＜ 0.05).Conclusions Intravenous injection of a small dose of heparin for newborn DIC is safe and effective and has fewer adverse reactions,and is worth being clinically generalized.
